| scholarly article | Q13442814 |
| P50 | author | Yi-Ling Lin | Q54378000 |
| P2093 | author name string | Chi-Huey Wong | |
| Jian-Jong Liang | |||
| Yi-Ling Lee | |||
| Yih-Shyun E Cheng | |||
| Ching-Yao Su | |||
| Jia-Tsong Jan | |||
| Kun-Hsien Lin | |||
| Shao-Ying Lin-Chu | |||
| Wen-I Huang | |||
| P2860 | cites work | Antiviral effects of an iminosugar derivative on flavivirus infections | Q27472863 |
| Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells | Q34467874 | ||
| Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d | Q34572848 | ||
| NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus | Q34999264 | ||
| The regulatory role of Valpha14 NKT cells in innate and acquired immune response. | Q35051569 | ||
| Quantitative microarray analysis of intact glycolipid-CD1d interaction and correlation with cell-based cytokine production | Q35684305 | ||
| Real-time monitoring of bacterial infection in vivo: development of bioluminescent staphylococcal foreign-body and deep-thigh-wound mouse infection models | Q35685576 | ||
| The immunoregulatory role of CD1d-restricted natural killer T cells in disease. | Q35811028 | ||
| Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids | Q35973205 | ||
| Natural killer T cell activation inhibits hepatitis B virus replication in vivo. | Q36368956 | ||
| Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines | Q36370322 | ||
| Glycolipids as immunostimulating agents | Q36517889 | ||
| The unique role of natural killer T cells in the response to microorganisms | Q36814724 | ||
| Synthesis and evaluation of an acyl-chain unsaturated analog of the Th2 biasing, immunostimulatory glycolipid, OCH. | Q37345148 | ||
| Natural killer T cells and autoimmune disease | Q37387439 | ||
| A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability | Q39861100 | ||
| In vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped viruses. | Q39985869 | ||
| A synthetic analog of alpha-galactosylceramide induces macrophage activation via the TLR4-signaling pathways | Q40143681 | ||
| Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity | Q40256744 | ||
| Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro | Q41172126 | ||
| Alpha-S-GalCer: synthesis and evaluation for iNKT cell stimulation | Q41763024 | ||
| Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection | Q43456638 | ||
| Recognition of bacterial glycosphingolipids by natural killer T cells | Q44582192 | ||
| Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production | Q44684458 | ||
| Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide | Q44733648 | ||
| Prophylaxis of lipopolysaccharide-induced shock by alpha-galactosylceramide | Q45068192 | ||
| Activation of natural killer T cells by alpha-galactosylceramide mediates clearance of bacteria in murine urinary tract infection | Q46478075 | ||
| NKT cells: what's in a name? | Q47895830 | ||
| Synthesis and in vitro evaluation of alpha-GalCer epimers | Q49026227 | ||
| Alpha-c-galactosylceramides: synthesis and immunology. | Q53586759 | ||
| Conserved and Heterogeneous Lipid Antigen Specificities of CD1d-Restricted NKT Cell Receptors | Q63362839 | ||
| KRN7000, a novel immunomodulator, and its antitumor activities | Q71674742 | ||
| Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice | Q72317791 | ||
| Pivotal advance: alpha-galactosylceramide induces protection against lipopolysaccharide-induced shock | Q79259827 | ||
| Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis | Q80388441 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ceramides | Q424213 |
| murine model | Q122890741 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 4129-4136 | |
| P577 | publication date | 2010-07-26 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | In vivo protection provided by a synthetic new alpha-galactosyl ceramide analog against bacterial and viral infections in murine models | |
| P478 | volume | 54 |
| Q87377516 | A concise synthesis of glycolipids based on aspartic acid building blocks |
| Q41639759 | Adjuvant effects of therapeutic glycolipids administered to a cohort of NKT cell-diverse pigs |
| Q35174495 | Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010. |
| Q35409604 | Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy |
| Q58551383 | Development of a universal influenza vaccine using hemagglutinin stem protein produced from Pichia pastoris |
| Q27676395 | Glycolipids that Elicit IFN-γ-Biased Responses from Natural Killer T Cells |
| Q37822744 | Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens |
| Q40752357 | Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research. |
| Q36804654 | Sulfatide attenuates experimental Staphylococcus aureus sepsis through a CD1d-dependent pathway. |
| Q64991911 | Synthesis of α-O- and α-S-glycosphingolipids related to Sphingomonous cell wall antigens using anomerisation. |
Search more.